These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1562 related articles for article (PubMed ID: 26318322)

  • 1. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.
    Wiebe J; Bertog S; Franke J; Wettstein O; Lehn K; Hofmann I; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):796-802. PubMed ID: 24327462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
    Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
    Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous left atrial appendage closure followed by single antiplatelet therapy: Short- and mid-term outcomes.
    Jalal Z; Dinet ML; Combes N; Pillois X; Renou P; Sibon I; Iriart X; Thambo JB
    Arch Cardiovasc Dis; 2017 Apr; 110(4):242-249. PubMed ID: 28065447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience.
    Price MJ; Reddy VY; Valderrábano M; Halperin JL; Gibson DN; Gordon N; Huber KC; Holmes DR
    JACC Cardiovasc Interv; 2015 Dec; 8(15):1925-1932. PubMed ID: 26627989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of catheter-based left atrial appendage closure in patients with contraindications for long-term anticoagulation.
    Seidel A; Parwani AS; Krackhardt F; Huemer M; Attanasio P; Haverkamp W; Pieske B; Boldt LH
    Minerva Cardioangiol; 2017 Dec; 65(6):545-552. PubMed ID: 28565887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous Left Atrial Appendage Closure With the Watchman Device: Long-Term Results Up to 5 Years.
    Wiebe J; Franke J; Lehn K; Hofmann I; Vaskelyte L; Bertog S; Sievert H
    JACC Cardiovasc Interv; 2015 Dec; 8(15):1915-1921. PubMed ID: 26738659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
    Ramlawi B; Abu Saleh WK; Edgerton J
    Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Canadian Multicenter Experience With WATCHMAN for Percutaneous Left Atrial Appendage Closure.
    Saw J; Fahmy P; Azzalini L; Marquis JF; Hibbert B; Morillo C; Carrizo A; Ibrahim R
    J Cardiovasc Electrophysiol; 2017 Apr; 28(4):396-401. PubMed ID: 28128883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual antiplatelet therapy after percutaneous left atrial appendage occlusion: single center experience with the Amplatzer Cardiac Plug.
    Bertrand PB; Habran M; Kenis K; Lecomte J; Moonen L; Stroobants D; Benit E
    Acta Cardiol; 2019 Feb; 74(1):74-81. PubMed ID: 29607737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in risk of stroke and bleeding after left atrial appendage closure with LARIAT device in patients with increased risk of stroke and bleeding: Long term results.
    Litwinowicz R; Bartus M; Kapelak B; Suwalski P; Lakkireddy D; Lee RJ; Bartus K
    Catheter Cardiovasc Interv; 2019 Nov; 94(6):837-842. PubMed ID: 30884101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decennial Analysis of Interventional Left Atrial Appendage Closure.
    Schmidt B; Bordignon S; Fuernkranz A; Perrotta L; Scherer D; Chun KRJ
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):840-844. PubMed ID: 25930020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous closure of the left atrial appendage for prevention of thromboembolism in atrial fibrillation for patients with contraindication to or failure of oral anticoagulation: a single-center experience.
    Faustino A; Paiva L; Providência R; Trigo J; Botelho A; Costa M; Leitão-Marques A
    Rev Port Cardiol; 2013 Jun; 32(6):461-71. PubMed ID: 23639325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left atrial appendage closure: First in man with the 4th generation WATCHMAN device.
    Ledwoch J; Franke J; Gonzaga M; Bertog S; Braut A; Hofmann I; Vaskelyte L; Gafoor S; Reddy V; Sievert H
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):787-94. PubMed ID: 26354821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial appendage occlusion in high-risk patients with non-valvular atrial fibrillation.
    Berti S; Pastormerlo LE; Rezzaghi M; Trianni G; Paradossi U; Cerone E; Ravani M; De Caterina AR; Rizza A; Palmieri C
    Heart; 2016 Dec; 102(24):1969-1973. PubMed ID: 27492943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).
    Reddy VY; Möbius-Winkler S; Miller MA; Neuzil P; Schuler G; Wiebe J; Sick P; Sievert H
    J Am Coll Cardiol; 2013 Jun; 61(25):2551-6. PubMed ID: 23583249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous closure of left atrial appendage to prevent embolic events in high-risk patients with chronic atrial fibrillation.
    Ussia GP; Mulè M; Cammalleri V; Scarabelli M; Barbanti M; Immè S; Mangiafico S; Marchese A; Galassi AR; Tamburino C
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):217-22. PubMed ID: 19472361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of sex differences on outcomes in patients with non-valvular atrial fibrillation undergoing left atrial appendage closure: A single-center experience.
    Zhao M; Post F; Muenzel M; Hou CR; Keil T; Yu J
    Int J Med Sci; 2021; 18(9):1990-1998. PubMed ID: 33850469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices.
    Weise FK; Bordignon S; Perrotta L; Konstantinou A; Bologna F; Nagase T; Chen S; Chun KRJ; Schmidt B
    EuroIntervention; 2018 Apr; 13(18):e2138-e2146. PubMed ID: 29400653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 79.